Sari, I. Et Al. 2014. THE COMPARATIVE ONE-YEAR DRUG SURVIVAL RATE OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY. 15th Annual European Congress of Rheumatology (EULAR) , (Paris, France), 425.

Sari, I., Kalyoncu, U., Onat, A. M., Pamuk, O. N., Karadag, O., Kisacik, B., ... Senel, S.(2014). THE COMPARATIVE ONE-YEAR DRUG SURVIVAL RATE OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY . 15th Annual European Congress of Rheumatology (EULAR) (pp.425). Paris, France

Sari, I. Et Al. "THE COMPARATIVE ONE-YEAR DRUG SURVIVAL RATE OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY," 15th Annual European Congress of Rheumatology (EULAR), Paris, France, 2014

Sari, I. Et Al. "THE COMPARATIVE ONE-YEAR DRUG SURVIVAL RATE OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY." 15th Annual European Congress of Rheumatology (EULAR) , Paris, France, pp.425, 2014

Sari, I. Et Al. (2014) . "THE COMPARATIVE ONE-YEAR DRUG SURVIVAL RATE OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY." 15th Annual European Congress of Rheumatology (EULAR) , Paris, France, p.425.

@conferencepaper{conferencepaper, author={I. Sari Et Al. }, title={THE COMPARATIVE ONE-YEAR DRUG SURVIVAL RATE OF TUMOR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS; RESULTS FROM TURKBIO REGISTRY}, congress name={15th Annual European Congress of Rheumatology (EULAR)}, city={Paris}, country={France}, year={2014}, pages={425} }